RxSight $RXST: Jefferies lowered its price target from $6.50 to $5.75 and maintained its Hold rating.
https://fundspec.ai/s/RXST/analysts
Screen valuation, momentum and options flow together in one place.
https://fundspec.ai/s/RXST/analysts
Screen valuation, momentum and options flow together in one place.
September 22, 2026 at 2:15 PM
RxSight $RXST: Jefferies lowered its price target from $6.50 to $5.75 and maintained its Hold rating.
https://fundspec.ai/s/RXST/analysts
Screen valuation, momentum and options flow together in one place.
https://fundspec.ai/s/RXST/analysts
Screen valuation, momentum and options flow together in one place.
Ma réaction honnête : ✋🤯🤚
www.youtube.com/watch?v=RXSt...
www.youtube.com/watch?v=RXSt...
LOVE LETTER TO HOLLOW KNIGHT - Briser le cycle
YouTube video by dahkrab
www.youtube.com
February 27, 2025 at 4:01 PM
Ma réaction honnête : ✋🤯🤚
www.youtube.com/watch?v=RXSt...
www.youtube.com/watch?v=RXSt...
February 27, 2025 at 4:24 PM
LOVE LETTER TO HOLLOW KNIGHT - Briser le cycle.
Je reviens sur Youtube avec une vidéo où je dis mon amour pour certaines oeuvres et artistes ! La première est plutôt légère pour se remettre dans le bain !
RT apprécié 🙏
www.youtube.com/watch?v=RXSt...
Je reviens sur Youtube avec une vidéo où je dis mon amour pour certaines oeuvres et artistes ! La première est plutôt légère pour se remettre dans le bain !
RT apprécié 🙏
www.youtube.com/watch?v=RXSt...
February 27, 2025 at 3:30 PM
LOVE LETTER TO HOLLOW KNIGHT - Briser le cycle.
Je reviens sur Youtube avec une vidéo où je dis mon amour pour certaines oeuvres et artistes ! La première est plutôt légère pour se remettre dans le bain !
RT apprécié 🙏
www.youtube.com/watch?v=RXSt...
Je reviens sur Youtube avec une vidéo où je dis mon amour pour certaines oeuvres et artistes ! La première est plutôt légère pour se remettre dans le bain !
RT apprécié 🙏
www.youtube.com/watch?v=RXSt...
August 3, 2024 at 2:15 PM
RxSight's Capital Equipment Sales Plunge 70%, Bleak 2026 Guidance Overshadows Earnings Beat https://signalbloom.ai/news/RXST/rxsights-capital-equipment-sales-plunge-70-bleak-2026-guidance-overshadows-earnings-beat $RXST #Earnings via @signalbloom.ai
February 25, 2026 at 9:10 PM
RxSight's Capital Equipment Sales Plunge 70%, Bleak 2026 Guidance Overshadows Earnings Beat https://signalbloom.ai/news/RXST/rxsights-capital-equipment-sales-plunge-70-bleak-2026-guidance-overshadows-earnings-beat $RXST #Earnings via @signalbloom.ai
#trading #stockmarket #stock #tariffs #liberation #crash
Tariffs smacked importers like Wayfair today. Took a big hit.
The top DOWN stock today is stock symbol RXST, Rxsight, Inc.with a HUGE negative StockQuakes level of -11.8.
See StockQuakes.com
Tariffs smacked importers like Wayfair today. Took a big hit.
The top DOWN stock today is stock symbol RXST, Rxsight, Inc.with a HUGE negative StockQuakes level of -11.8.
See StockQuakes.com
April 3, 2025 at 10:31 PM
#trading #stockmarket #stock #tariffs #liberation #crash
Tariffs smacked importers like Wayfair today. Took a big hit.
The top DOWN stock today is stock symbol RXST, Rxsight, Inc.with a HUGE negative StockQuakes level of -11.8.
See StockQuakes.com
Tariffs smacked importers like Wayfair today. Took a big hit.
The top DOWN stock today is stock symbol RXST, Rxsight, Inc.with a HUGE negative StockQuakes level of -11.8.
See StockQuakes.com
$RXST -39.8% [RxSight cut Q2 revenue guidance to $33.6 million and full-year guidance to $120 million–$130 million, below analyst expectations, due to worsening trends and a 49% drop in light delivery device sales.] investors.rxsight.com/news-release...
investors.rxsight.com
July 9, 2025 at 11:33 AM
$RXST -39.8% [RxSight cut Q2 revenue guidance to $33.6 million and full-year guidance to $120 million–$130 million, below analyst expectations, due to worsening trends and a 49% drop in light delivery device sales.] investors.rxsight.com/news-release...
$APVO announced a $2.1 million offering, issuing 1.76 million shares at $1.19 each and warrants for 3.53 million shares in a concurrent private placement.
See More Biotech Updates👇
www.biopharmcatalyst.com/news/2025/ap...
$RXST $SGMO $NMTC $NIVF $ALDX $NPCE $NVCT $INMB
See More Biotech Updates👇
www.biopharmcatalyst.com/news/2025/ap...
$RXST $SGMO $NMTC $NIVF $ALDX $NPCE $NVCT $INMB
April 3, 2025 at 8:40 PM
$APVO announced a $2.1 million offering, issuing 1.76 million shares at $1.19 each and warrants for 3.53 million shares in a concurrent private placement.
See More Biotech Updates👇
www.biopharmcatalyst.com/news/2025/ap...
$RXST $SGMO $NMTC $NIVF $ALDX $NPCE $NVCT $INMB
See More Biotech Updates👇
www.biopharmcatalyst.com/news/2025/ap...
$RXST $SGMO $NMTC $NIVF $ALDX $NPCE $NVCT $INMB
$MRK will acquire $VRNA for $107 per ADS in a deal valued at approximately $10 billion, securing full ownership of Verona’s respiratory drug assets.
See More Pre-market Movers 👇
www.biopharmcatalyst.com/news/2025/ka...
$KZIA $EVOK $PROK $ARTL $RXST $BCTX $BNTC $RYTM $ZVSA
See More Pre-market Movers 👇
www.biopharmcatalyst.com/news/2025/ka...
$KZIA $EVOK $PROK $ARTL $RXST $BCTX $BNTC $RYTM $ZVSA
July 9, 2025 at 12:33 PM
$MRK will acquire $VRNA for $107 per ADS in a deal valued at approximately $10 billion, securing full ownership of Verona’s respiratory drug assets.
See More Pre-market Movers 👇
www.biopharmcatalyst.com/news/2025/ka...
$KZIA $EVOK $PROK $ARTL $RXST $BCTX $BNTC $RYTM $ZVSA
See More Pre-market Movers 👇
www.biopharmcatalyst.com/news/2025/ka...
$KZIA $EVOK $PROK $ARTL $RXST $BCTX $BNTC $RYTM $ZVSA
In macro news, March ISM services came in weaker, printing at 50.8 versus consensus for 53.0.
$MSFT, $INTC, $TSM, $COF, $DFS, $HSY, $CAG, $LW, $AYI, $RH, $RXST, $LSTR, $MSM
Gain immediate access to unparalleled insights with #StreetAccount: www.streetaccount.com/subscription...
$MSFT, $INTC, $TSM, $COF, $DFS, $HSY, $CAG, $LW, $AYI, $RH, $RXST, $LSTR, $MSM
Gain immediate access to unparalleled insights with #StreetAccount: www.streetaccount.com/subscription...
StreetAccount
defining market intelligence
www.streetaccount.com
April 3, 2025 at 8:41 PM
In macro news, March ISM services came in weaker, printing at 50.8 versus consensus for 53.0.
$MSFT, $INTC, $TSM, $COF, $DFS, $HSY, $CAG, $LW, $AYI, $RH, $RXST, $LSTR, $MSM
Gain immediate access to unparalleled insights with #StreetAccount: www.streetaccount.com/subscription...
$MSFT, $INTC, $TSM, $COF, $DFS, $HSY, $CAG, $LW, $AYI, $RH, $RXST, $LSTR, $MSM
Gain immediate access to unparalleled insights with #StreetAccount: www.streetaccount.com/subscription...
#RXST RxSight, Inc. to Participate in the Wells Fargo Healthcare Conference
https://www.stocktitan.net/news/RXST/rx-sight-inc-to-participate-in-the-wells-fargo-healthcare-sz2453ik0zmc.html
https://www.stocktitan.net/news/RXST/rx-sight-inc-to-participate-in-the-wells-fargo-healthcare-sz2453ik0zmc.html
RxSight management is scheduled to speak in Boston on Sept. 9
The presentation is scheduled for 9:30 a.m. ET in Boston, with a live and archived webcast available on RxSight’s investor relations website.
www.stocktitan.net
August 26, 2026 at 8:15 PM
#RXST RxSight, Inc. to Participate in the Wells Fargo Healthcare Conference
https://www.stocktitan.net/news/RXST/rx-sight-inc-to-participate-in-the-wells-fargo-healthcare-sz2453ik0zmc.html
https://www.stocktitan.net/news/RXST/rx-sight-inc-to-participate-in-the-wells-fargo-healthcare-sz2453ik0zmc.html
🚨 $RXST
RAYMOND W COHEN, a Former Director, filed a notice of intent to sell 11,890 shares of common stock, valued at approximately $75,748.81, on 08/18/2026.
RAYMOND W COHEN, a Former Director, filed a notice of intent to sell 11,890 shares of common stock, valued at approximately $75,748.81, on 08/18/2026.
SEC Filing: RXST
Click to view the official SEC document.
www.sec.gov
August 18, 2026 at 11:06 PM
🚨 $RXST
RAYMOND W COHEN, a Former Director, filed a notice of intent to sell 11,890 shares of common stock, valued at approximately $75,748.81, on 08/18/2026.
RAYMOND W COHEN, a Former Director, filed a notice of intent to sell 11,890 shares of common stock, valued at approximately $75,748.81, on 08/18/2026.
Could Alcon (ALC) and RxSight (RXST)’s Partnership Reshape the Future of Cataract Surgery?
Could Alcon (ALC) and RxSight (RXST)’s Partnership Reshape the Future of Cataract Surgery? - BeyondLink
Two ophthalmic technology leaders, Alcon Inc. (NYSE:ALC) and RxSight, Inc. (NASDAQ:RXST), earlier on July 6 entered into a strategic collaboration that
beyondlink.live
August 15, 2026 at 4:03 AM
Could Alcon (ALC) and RxSight (RXST)’s Partnership Reshape the Future of Cataract Surgery?
RxSight's Alcon Deal Masks 19% Plunge in Core Product Sales, Guidance Abruptly Withdrawn https://signalbloom.ai/news/RXST/rxsights-alcon-deal-masks-19-plunge-in-core-product-sales-guidance-abruptly-withdrawn $RXST #Earnings via @signalbloom.ai
August 5, 2026 at 8:30 PM
RxSight's Alcon Deal Masks 19% Plunge in Core Product Sales, Guidance Abruptly Withdrawn https://signalbloom.ai/news/RXST/rxsights-alcon-deal-masks-19-plunge-in-core-product-sales-guidance-abruptly-withdrawn $RXST #Earnings via @signalbloom.ai
#RXST RxSight, Inc. Reports Second Quarter 2026 Results and Provides Update on 2026 Outlook
https://www.stocktitan.net/news/RXST/rx-sight-inc-reports-second-quarter-2026-results-and-provides-update-jhka4dcvcg7z.html
https://www.stocktitan.net/news/RXST/rx-sight-inc-reports-second-quarter-2026-results-and-provides-update-jhka4dcvcg7z.html
RxSight, Inc. Reports Second Quarter 2026 Results and Provides Update on 2026 Outlook
RxSight (NASDAQ: RXST) reported Q2 2026 revenue of $33.7 million, essentially flat year over year, including $6.5 million from its new strategic collaboration with Alcon. Product sales were $27.2 million, down 19%, with 24,917 Light Adjustable Lens units and 12 Light Delivery Devices sold.Excluding collaboration revenue, gross margin was 71.2% versus 74.9% a year ago; including it, gross margin was 76.7%. Operating expenses were $39.7 million. Net loss was $12.1 million (basic and diluted $(0.29) per share). Adjusted net loss was $4.6 million, or $(0.11) per share. Cash, cash equivalents and short-term investments totaled $208.8 million on June 30, 2026.RxSight appointed Aziz Mottiwala as President and CEO, entered a collaboration with Alcon that includes up to $200 million in upfront and milestone payments plus future royalties, and announced development of a next-generation Light Adjustable Technology platform. In connection with the leadership transition, the company withdrew its 2026 guidance and plans to resume formal guidance in early 2027.
www.stocktitan.net
August 5, 2026 at 8:05 PM
#RXST RxSight, Inc. Reports Second Quarter 2026 Results and Provides Update on 2026 Outlook
https://www.stocktitan.net/news/RXST/rx-sight-inc-reports-second-quarter-2026-results-and-provides-update-jhka4dcvcg7z.html
https://www.stocktitan.net/news/RXST/rx-sight-inc-reports-second-quarter-2026-results-and-provides-update-jhka4dcvcg7z.html
Watchlist update (+13/-15)
Added: OLMA (dynamic screener passed volatility filter (ADR >=5.0% over 14d)); RXST (dynamic screener passed volatility filter (ADR >=5.0% over 14d)); +11 more
Removed: EAF (rotated out by dynamic screener/volatility filter); UMAC (rotated out by dynamic screener/volati...
Added: OLMA (dynamic screener passed volatility filter (ADR >=5.0% over 14d)); RXST (dynamic screener passed volatility filter (ADR >=5.0% over 14d)); +11 more
Removed: EAF (rotated out by dynamic screener/volatility filter); UMAC (rotated out by dynamic screener/volati...
July 28, 2026 at 8:55 PM
Watchlist update (+13/-15)
Added: OLMA (dynamic screener passed volatility filter (ADR >=5.0% over 14d)); RXST (dynamic screener passed volatility filter (ADR >=5.0% over 14d)); +11 more
Removed: EAF (rotated out by dynamic screener/volatility filter); UMAC (rotated out by dynamic screener/volati...
Added: OLMA (dynamic screener passed volatility filter (ADR >=5.0% over 14d)); RXST (dynamic screener passed volatility filter (ADR >=5.0% over 14d)); +11 more
Removed: EAF (rotated out by dynamic screener/volatility filter); UMAC (rotated out by dynamic screener/volati...
#RXST RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
https://www.stocktitan.net/news/RXST/rx-sight-reports-inducement-grants-as-permitted-by-the-nasdaq-nrwhwqmmqova.html
https://www.stocktitan.net/news/RXST/rx-sight-reports-inducement-grants-as-permitted-by-the-nasdaq-nrwhwqmmqova.html
RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
RxSight (NASDAQ: RXST) reported that on July 24, 2026 it granted inducement equity awards to new President and CEO Aziz Mottiwala in connection with his employment. The awards include stock options for 571,286 shares at an exercise price of $5.19 and RSUs covering 2,312,138 shares.The options vest 25% on the one-year anniversary of July 24, 2026, with the remainder vesting in equal monthly installments over the following three years. The RSUs vest 20% on each of the first two anniversaries and 60% on the third anniversary. The grants were made under the 2026 Inducement Equity Incentive Plan pursuant to Nasdaq Listing Rule 5635(c)(4).
www.stocktitan.net
July 26, 2026 at 8:00 PM
#RXST RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
https://www.stocktitan.net/news/RXST/rx-sight-reports-inducement-grants-as-permitted-by-the-nasdaq-nrwhwqmmqova.html
https://www.stocktitan.net/news/RXST/rx-sight-reports-inducement-grants-as-permitted-by-the-nasdaq-nrwhwqmmqova.html
🚨 $RXST
Mottiwala Aziz (President and CEO) filed Form 3 reporting no initial stock ownership.
Mottiwala Aziz (President and CEO) filed Form 3 reporting no initial stock ownership.
SEC Filing: RXST
Click to view the official SEC document.
www.sec.gov
July 25, 2026 at 12:06 AM
🚨 $RXST
Mottiwala Aziz (President and CEO) filed Form 3 reporting no initial stock ownership.
Mottiwala Aziz (President and CEO) filed Form 3 reporting no initial stock ownership.
🚨 $RXST
Mottiwala Aziz (President and CEO) reported special transactions (Non-P/S).
Mottiwala Aziz (President and CEO) reported special transactions (Non-P/S).
SEC Filing: RXST
Click to view the official SEC document.
www.sec.gov
July 25, 2026 at 12:08 AM
🚨 $RXST
Mottiwala Aziz (President and CEO) reported special transactions (Non-P/S).
Mottiwala Aziz (President and CEO) reported special transactions (Non-P/S).
🚨 $RXST
Mottiwala Aziz (President and CEO) filed Form 3 reporting no initial stock ownership.
Mottiwala Aziz (President and CEO) filed Form 3 reporting no initial stock ownership.
SEC Filing: RXST
Click to view the official SEC document.
www.sec.gov
July 25, 2026 at 12:06 AM
🚨 $RXST
Mottiwala Aziz (President and CEO) filed Form 3 reporting no initial stock ownership.
Mottiwala Aziz (President and CEO) filed Form 3 reporting no initial stock ownership.
Research Analysts’ Weekly Ratings Changes for RxSight (RXST)
Several brokerages have updated their recommendations and price targets on shares of RxSight (NASDAQ: RXST) in the last few weeks: 7/12/2026 – RxSight was upgraded by Wall Street Zen from “strong sell” to “sell”. 7/7/2026 – RxSight was…
Several brokerages have updated their recommendations and price targets on shares of RxSight (NASDAQ: RXST) in the last few weeks: 7/12/2026 – RxSight was upgraded by Wall Street Zen from “strong sell” to “sell”. 7/7/2026 – RxSight was…
Research Analysts’ Weekly Ratings Changes for RxSight (RXST)
Several brokerages have updated their recommendations and price targets on shares of RxSight (NASDAQ: RXST) in the last few weeks: 7/12/2026 – RxSight was upgraded by Wall Street Zen from “strong sell” to “sell”. 7/7/2026 – RxSight was given a new $6.50 price target by Jefferies Financial Group Inc.. 7/7/2026 – RxSight had its price [...]
news-area.com
July 16, 2026 at 12:58 AM
Research Analysts’ Weekly Ratings Changes for RxSight (RXST)
Several brokerages have updated their recommendations and price targets on shares of RxSight (NASDAQ: RXST) in the last few weeks: 7/12/2026 – RxSight was upgraded by Wall Street Zen from “strong sell” to “sell”. 7/7/2026 – RxSight was…
Several brokerages have updated their recommendations and price targets on shares of RxSight (NASDAQ: RXST) in the last few weeks: 7/12/2026 – RxSight was upgraded by Wall Street Zen from “strong sell” to “sell”. 7/7/2026 – RxSight was…
🚨 $RXST
On July 15, 2026, the Company issued a press release announcing the appointment of Mr. Mottiwala as President and Chief Executive Officer of the Company and the transition of Dr. Kurtz to Chief Medical Officer.
On July 15, 2026, the Company issued a press release announcing the appointment of Mr. Mottiwala as President and Chief Executive Officer of the Company and the transition of Dr. Kurtz to Chief Medical Officer.
SEC Filing: RXST
Click to view the official SEC document.
www.sec.gov
July 15, 2026 at 8:24 PM
🚨 $RXST
On July 15, 2026, the Company issued a press release announcing the appointment of Mr. Mottiwala as President and Chief Executive Officer of the Company and the transition of Dr. Kurtz to Chief Medical Officer.
On July 15, 2026, the Company issued a press release announcing the appointment of Mr. Mottiwala as President and Chief Executive Officer of the Company and the transition of Dr. Kurtz to Chief Medical Officer.
#RXST RxSight Announces Appointments of Aziz Mottiwala as Chief Executive Officer and Ron Kurtz, M.D. as Chief Medical Officer
https://www.stocktitan.net/news/RXST/rx-sight-announces-appointments-of-aziz-mottiwala-as-chief-executive-f1ts43yybnya.html
https://www.stocktitan.net/news/RXST/rx-sight-announces-appointments-of-aziz-mottiwala-as-chief-executive-f1ts43yybnya.html
RxSight CEO Ron Kurtz to Continue as Chief Medical Officer
Mottiwala brings eye-care commercial experience from Tarsus, Opiant and Allergan; RxSight plans the transition for July 20 with guidance unchanged.
www.stocktitan.net
July 15, 2026 at 8:15 PM
#RXST RxSight Announces Appointments of Aziz Mottiwala as Chief Executive Officer and Ron Kurtz, M.D. as Chief Medical Officer
https://www.stocktitan.net/news/RXST/rx-sight-announces-appointments-of-aziz-mottiwala-as-chief-executive-f1ts43yybnya.html
https://www.stocktitan.net/news/RXST/rx-sight-announces-appointments-of-aziz-mottiwala-as-chief-executive-f1ts43yybnya.html
Buy $RXST (RXST.O) @ 20:15:15Z
July 6, 2026 at 8:15 PM
Buy $RXST (RXST.O) @ 20:15:15Z